DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Dent R, Andre F, Goncalves A. et al.
IMpassion132: A double-blind randomized phase 3 trial evaluating chemotherapy (CT) ± atezolizumab (atezo) for early progressing locally advanced/metastatic triple-negative breast cancer (mTNBC).
ASCO J Clin Oncol 2018;
36 (Suppl.) TPS1115
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.